India is facing an escalating obesity crisis, and health experts are urging the government to take stronger action. Luke ...

Addressing obesity is not a one-size-fits-all approach, Dr. Sam Wilcox told a capacity Lunch & Learn crowd in Iola Wednesday.

Sales of Novo Nordisk’s obesity drugs, such as Wegovy, rose by more than 50 per cent last year, helping send shares in Europe’s most valuable listed company almost 5 per cent higher.

LONDON/COPENHAGEN, Feb 5 (Reuters) - Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data published in December that disappointed ...

Novo had suggested they would conduct further trials when the Phase 3 study Redefine-1 read out in December. On Wednesday, alongside earnings for the fourth quarter, executives gave further detail on ...

Sales in International Operations increased by 17% in Danish kroner. Sales within Diabetes and Obesity care increased by 26% in Danish kroner to DKK 271.8 billion, mainly driven by GLP-1 diabetes ...

Amgen’s mysterious obesity asset will remain a mystery for a bit longer—the FDA has put the candidate’s phase 1 trial on a clinical hold, the company announced Feb. 4. Amgen has not detailed ...

LONDON/SAN FRANCISCO, Feb 4 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema amid ...

The influence of loneliness on obesity and health-related habits showed some variation across life stages. For example, obesity and loneliness showed the strongest association among adolescents ...

These drugs are believed to have contributed to the first decrease in US obesity rates in more than a decade. Could they also signal the death of appetite as we know it? Polls from 2024 show one ...

on March 1, 2024. (AP Photo/Amanda Andrade-Rhoades, File) More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they ...

Indeed, the study says numbers are expected to increase to 80% and 60%, respectively, in about 25 years. The obesity epidemic is a brake on the average life expectancy in the U.S. Obesity is estimated ...